Our Pricing

Weight Loss Clinic in Birmingham: Expert Prescription Treatment

Published: 29 September 2026

Finding a reliable weight loss clinic in Birmingham has become significantly easier with the advent of UK-registered online pharmacy services that combine clinical expertise with convenient access to prescription treatments. At Cured Pharmacy, our Birmingham patients benefit from the same rigorous clinical standards as traditional face-to-face clinics, with consultations conducted by UK-registered prescribers and genuine licensed medications delivered discreetly to your door. Whether you're considering Mounjaro, Wegovy, Saxenda, or other evidence-based treatments, our clinical team provides personalised weight loss support starting from £124.99, with £20 off your first order using code Weightlossnew.

What Services Does a Weight Loss Clinic in Birmingham Provide?

A comprehensive weight loss clinic in Birmingham should offer clinical assessment, prescription medication management, and ongoing support tailored to individual health profiles. At Cured Pharmacy, our service mirrors traditional clinic offerings while removing geographical barriers: every patient completes a detailed medical consultation reviewed by a UK-registered prescriber (GPhC-registered), ensuring treatments like Mounjaro (tirzepatide) or Wegovy (semaglutide) are clinically appropriate before dispensing [1].

Our Birmingham patients access the same range of prescription treatments available at physical clinics, including GLP-1 receptor agonists that have demonstrated significant efficacy in clinical trials. The STEP programme trials showed semaglutide (Wegovy) achieved average weight reductions of 12-15% over 68 weeks, while SURPASS trials demonstrated tirzepatide (Mounjaro) resulted in up to 22.5% weight reduction at the highest dose [2]. All medications are MHRA-licensed and sourced from UK-regulated suppliers, with transparent pricing displayed before consultation—Mounjaro from £124.99, Wegovy from £124.99, and Saxenda from £124.99.

Beyond medication supply, a quality weight loss clinic in Birmingham provides continuity of care through follow-up support, dosage titration guidance, and side effect management. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team remain available via phone (+44 116 4646009) throughout your treatment journey, ensuring you receive the same duty of care as any traditional clinic setting.

Prescription Weight Loss Medications Available Through Weight Loss Clinic in Birmingham

The most effective treatments offered by any reputable weight loss clinic in Birmingham are prescription-only medications that work through distinct mechanisms to support significant weight reduction. Mounjaro (tirzepatide) represents the latest advancement—a dual GIP/GLP-1 receptor agonist that addresses both glucose regulation and appetite control, demonstrating superior weight loss outcomes compared to earlier GLP-1 therapies in head-to-head trials [3].

Wegovy (semaglutide) remains a highly effective option, particularly for patients who respond well to GLP-1 receptor agonist therapy. This once-weekly injection has been extensively studied across the STEP trial programme, showing consistent weight reduction alongside improvements in cardiovascular risk markers and glycaemic control in patients with type 2 diabetes [4]. For patients preferring oral medication, Wegovy tablets (from £124.99) offer comparable efficacy to the injection formulation, though absorption considerations may influence prescriber recommendations.

Saxenda (liraglutide) provides a daily injection alternative that has been available longer than newer GLP-1 therapies, offering a well-established safety profile with average weight reductions of 5-10% in clinical trials. For patients unsuitable for injectable therapies, Orlistat (from £124.99) and its branded version Xenical work through fat absorption inhibition, reducing dietary fat uptake by approximately 30% when combined with a reduced-calorie diet [5].

How Prescription Treatments Work

GLP-1 and dual GIP/GLP-1 receptor agonists work by mimicking incretin hormones that regulate appetite, slow gastric emptying, and enhance insulin secretion. Patients typically report reduced hunger, earlier satiety, and decreased food cravings—physiological changes that support adherence to calorie-reduced diets. Orlistat operates through a completely different mechanism, blocking pancreatic lipase enzymes to prevent fat digestion, making it suitable for patients who cannot tolerate or are contraindicated for incretin-based therapies.

Clinical Assessment Process at Weight Loss Clinic in Birmingham

Every prescription issued through a weight loss clinic in Birmingham—whether online or face-to-face—must comply with MHRA and GPhC regulations requiring individualised clinical assessment. Our online consultation takes under 3 minutes to complete and covers essential medical history including cardiovascular health, previous weight loss attempts, current medications, and contraindications specific to GLP-1 therapies such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [6].

A UK-registered prescriber reviews every consultation within hours, assessing suitability based on BMI thresholds (typically ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities), existing health conditions, and medication interactions. This mirrors NICE guidance for prescription weight loss medication, ensuring treatments are reserved for patients who will derive clinical benefit. If a prescriber identifies any concerns or requires additional information, they will contact you directly before approving treatment.

Following approval, medications are dispensed from our UK-registered pharmacy (GPhC 9012511) and dispatched in 100% discreet packaging with next-day delivery options. Ongoing clinical support includes dosage escalation guidance—particularly important for tirzepatide and semaglutide, which follow structured titration schedules to minimise gastrointestinal side effects—and monitoring for adverse reactions throughout treatment.

Cost of Weight Loss Clinic in Birmingham Services and Treatments

Transparent pricing distinguishes quality weight loss clinic services in Birmingham from those that obscure costs until after consultation. At Cured Pharmacy, all treatment prices are displayed upfront: Mounjaro from £124.99, Wegovy injections from £124.99, Wegovy tablets from £124.99, Saxenda from £124.99, Orlistat from £124.99, Xenical from £124.99, and Foundayo from £124.99. New patients receive £20 off their first order using code Weightlossnew, reducing initial costs to £124.99 for Mounjaro or proportionally for other treatments.

These prices include clinical consultation, prescriber review, medication supply, and discreet home delivery—representing comprehensive care comparable to traditional clinic fees without additional consultation charges or hidden costs. Many Birmingham residents find online pharmacy services offer better value than face-to-face clinics that charge separate consultation fees (often £124.99-150) before medication costs, particularly for ongoing monthly prescriptions.

Treatment duration varies by individual response and weight loss goals, with most patients continuing therapy for 6-12 months to achieve and maintain clinically significant weight reduction. Our lowest price guarantee ensures Birmingham patients access competitive UK pricing without compromising on clinical standards, regulatory compliance, or medication authenticity.

Insurance and Private Payment Options

Most UK private health insurance policies do not cover prescription weight loss medications, as they are typically considered lifestyle treatments rather than medical necessities, even when prescribed for obesity-related health conditions. Cured Pharmacy accepts all major UK payment methods including credit cards, debit cards, and digital payment platforms, with secure checkout and no requirement for upfront membership fees or subscription commitments.

Benefits of Online Weight Loss Clinic in Birmingham vs Traditional Clinics

While traditional face-to-face weight loss clinics in Birmingham provide valuable in-person support, UK-registered online pharmacy services offer several advantages without compromising clinical standards. Geographic accessibility eliminates travel time and parking costs, particularly beneficial for Birmingham residents in areas with limited clinic availability or those with mobility challenges. Our 3-minute online consultation can be completed at any time, with prescriber review typically completed within hours rather than waiting days or weeks for clinic appointments [7].

Clinical outcomes for weight loss medications depend on the medication itself and patient adherence—not the consultation format. The same MHRA-licensed Mounjaro, Wegovy, and Saxenda prescribed by Birmingham face-to-face clinics are dispensed through our GPhC-registered pharmacy, with identical dosing protocols, titration schedules, and monitoring recommendations. Our UK-registered prescribers apply the same clinical criteria and contraindication screening as any traditional clinic, ensuring patient safety remains paramount.

Cost transparency represents another significant advantage: online services typically display full treatment costs before consultation, whereas traditional clinics may require paid initial appointments before discussing medication options and ongoing costs. Discreet home delivery also appeals to patients who prefer privacy regarding weight loss treatment, with medications arriving in unmarked packaging that reveals no information about contents or pharmacy identity.

Safety and Regulation of Weight Loss Clinic in Birmingham Services

Any weight loss clinic operating in Birmingham—online or physical—must comply with stringent UK pharmaceutical regulations enforced by the MHRA, GPhC, and Care Quality Commission. Cured Pharmacy operates under GPhC registration 9012511, with superintendent pharmacist Tarun Kumar (GPhC 2233073) ensuring all dispensing, prescribing, and patient safety protocols meet regulatory standards. Every prescription medication undergoes clinical review by UK-registered prescribers who hold active GMC or GPhC registration, maintaining the same professional accountability as hospital or GP prescribers [8].

Medication authenticity represents a critical safety consideration, particularly given the proliferation of counterfeit weight loss drugs. All treatments dispensed through our pharmacy are sourced directly from UK-licensed wholesalers and manufacturers, with full supply chain documentation and batch traceability. Mounjaro, Wegovy, Saxenda, and other prescription treatments arrive in original manufacturer packaging with patient information leaflets, ensuring you receive genuine medication identical to that supplied through NHS or private hospital pharmacies.

Patient safety monitoring includes clear guidance on recognising and managing side effects, contraindications screening for conditions like pancreatitis or severe gastrointestinal disease, and advice on when to seek urgent medical attention. Our clinical team remains accessible throughout treatment via phone and email, providing the ongoing support that characterises responsible weight loss clinic services in Birmingham and across the UK.

Reporting Side Effects and Adverse Reactions

All prescription medications carry potential side effects, with GLP-1 therapies most commonly causing transient nausea, diarrhoea, and constipation during initial weeks and dose escalations. Patients should report persistent or severe symptoms to their prescriber immediately. Serious adverse reactions can also be reported directly to the MHRA Yellow Card Scheme, contributing to ongoing medication safety surveillance that protects all UK patients.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 29 September 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 29 September 2026]
3. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. [accessed 29 September 2026]
4. Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984. [accessed 29 September 2026]
5. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155-161. [accessed 29 September 2026]
6. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management. NICE Clinical Guideline [CG189]. [accessed 29 September 2026]
7. Wadden, T. A., Bailey, T. S., Billings, L. K., et al. (2021). Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity. JAMA, 325(14), 1403-1413. [accessed 29 September 2026]
8. Medicines and Healthcare products Regulatory Agency. (2023). Good practice guidance for healthcare professionals on the prescribing of unlicensed medicinal products. MHRA Guidance. [accessed 29 September 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 29 September 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 29 September 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 29 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.